Please join us for a career panel with a diverse array of panelists. The panel is open to all Harvard undergraduate and graduate students. The event will be followed by a celebratory end-of-year dinner for participants in the WiSTEM Mentorship Program.
RSVP here: https://bit.ly/2GB42sX
-Alissa Fernald MS: Staff Engineer at Acceleron Pharma (biotechnology, pharmaceuticals)
-Anna Turetsky, PhD: Vice President at Lightstone Ventures (intellectual property, venture capital)
-H. Hahn Chu, MS: Program Manager at Mass Executive Office of --Energy and Environmental Affairs (policy, data analysis)
-Kim Noij, MD: Research Fellow at Massachusetts Eye & Ear Hospital (medicine, clinical research)
-A. Sydney Gladman, PhD: Senior Associate at Exponent (consulting, engineering)
-Rachel Sha, MBA: Vice President of Digital Business Development at Sanofi (digital health, business)
*************Complete bios of panelists*************
Alissa Fernald: Staff Engineer at Acceleron Pharma (biotechnology, pharmaceuticals)
Alissa holds a bachelors in chemical engineering from Northeastern and a masters in bioengineering from UPenn. She is a chemical and bioengineer working at Acceleron Pharma in the process development group. Acceleron Pharma is a biotechnology company working to develop therapeutics for serious and rare diseases. Prior to working at Acceleron, Alissa worked at the Vaccine Production Program Laboratory at the NIH and at Amplimmune, a biotechnology startup developing antibody therapeutics.
H. Hahn Chu: Program Manager at Mass Executive Office of Energy and Environmental Affairs (policy, data analysis)
Hahn holds a bachelors in anthropology and a masters degree in environmental science from SUNY College of Environmental Sciences and Forestry. She has been a Conservation Practitioner for The Nature Conservatory, Watershed Research Assistant for Americorp, and an Emissions Data Analyst. In her current position Hanh has coordinated an update of the Massachusetts Clean Energy and Climate Plan for 2020 and facilitated the progress evaluation of policies. She also manages a multi-disciplinary external stakeholder group tasked with advising the MA Executive Office of Energy and Environmental Affairs on the implementation of the Global Warming Solutions Act of 2008.
Anna Turetsky, PhD: Vice President at Lightstone Ventures (intellectual property, venture capital)
Anna received her bachelors in biochemistry from UPenn and her PhD in biophysics from Harvard University where she was a National Science Foundation Graduate Research Fellow and an Early Technology Assessment Fellow at the Harvard Office of Technology Development. She also completed internships with Siemens Venture Capital and consulting for Innotrove, LLC, an advisor to Merck’s MRL Ventures. Before joining Lightstone, Anna was an Analyst at Fletcher Spaght Inc., a healthcare strategy consulting firm in Boston. In her current position, Anna evaluates new investment opportunities in the biopharmaceutical and medical device sectors out of the Lightstone Venture's Boston office.
Kim Noij: Research Fellow at Massachusetts Eye & Ear Hospital (medicine, clinical research)
Kim received her medical degree at VU University in Amsterdam in 2015 after which she started her PhD. She is currently a third year visiting graduate student at the Massachusetts Eye and Ear Infirmary focusing on a vestibular test to improve evaluation and diagnosis of patients with dizziness. Prior to working at Mass Eye & Ear, Kim worked in blood collection at Atalmedial and as a hypertension surgery assistant at Antoni van Leeuwenhoek hospital. In the future, Kim would like to combine work in the clinic with research.
A. Sydney Gladman, PhD: Senior Associate at Exponent (consulting, engineering)
Sydney received her bachelors in materials science and engineering from University of Florida and her PhD in engineering sciences from Harvard University. Her research interests include the design, formulation and characterization of advanced polymeric materials, many of which are tailored for additive manufacturing processes such as 3D printing. Specifically, her innovative research in 4D printing has enabled shape changing behavior in a variety of fiber-reinforced acrylamide ink formulations, with the resulting programmable transformation triggered by water, heat, or light. Sydney currently works at Exponent, an engineering and scientific consulting firm in their Polymer Science & Materials Chemistry division.
Rachel Sha, MBA: Vice President of Digital Business Development at Sanofi (digital health, business)
Rachel received her bachelors in chemistry from MIT and her MBA from Harvard Business School. Prior to Sanofi, Rachel was the Director of Corporate Development at Genzyme. In her current position, Rachel negotiates agreements with digital companies to support and grow Sanofi’s digital strategy. Her focus areas include acceleration of drug discovery, clinical development, digital health opportunities from hardware (e.g. wearable sensors, diagnostics, connected drug delivery devices) to software (e.g. machine learning / advanced analytics, clinical decision support tools, population health management, patient engagement) to innovative care deliver models (e.g. telehealth, remote monitoring, AI/chatbots).
Please contact Nicole Black at firstname.lastname@example.org with any questions or concerns. The Women in Science, Technology, Engineering, and Math (WiSTEM) program is sponsored by the Harvard College Women’s Center.